(Q81601968)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

Demonstration of specific antibodies against infliximab induced during treatment of a patient with ankylosing spondylitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

main subject

ankylosing spondylitis

1 reference

Canan Aybay

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sumru Ozel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Cemalettin Aybay

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

9 December 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

Rheumatology International

10 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

473-480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16341700%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00296-005-0085-0

10 January 2020

exact match

0 references

cites work

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

12 December 2020

TNF receptor subtype signalling: differences and cellular consequences

1 reference

12 December 2020

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index

1 reference

12 December 2020

Developing a new generation of TNFalpha antagonists for the treatment of rheumatoid arthritis

1 reference

12 December 2020

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

12 December 2020

An update on the Bath Ankylosing Spondylitis Disease Activity and Functional Indices (BASDAI, BASFI): excellent Cronbach's alpha scores

1 reference

12 December 2020

Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study

1 reference

12 December 2020

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

1 reference

12 December 2020

The TNF-TNF receptor system

1 reference

12 December 2020

Tumor necrosis factor receptor and Fas signaling mechanisms.

1 reference

12 December 2020

Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study

1 reference

12 December 2020

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

12 December 2020

Optimizing anti-tumor necrosis factor strategies in inflammatory bowel disease

1 reference

12 December 2020

Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis

1 reference

12 December 2020

Clinical trials of antibody therapy

1 reference

12 December 2020

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

1 reference

12 December 2020

[Treatment of primary systemic vasculitis with TNF alpha-antagonists]

1 reference

12 December 2020

Development of a rapid, single-step procedure using protein G affinity chromatography to deplete fetal calf serum of its IgG and to isolate murine IgG1 monoclonal antibodies from supernatants of hybridoma cells

1 reference

12 December 2020

Effectiveness of psoriatic arthritis therapies

1 reference

12 December 2020

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

12 December 2020

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

12 December 2020

Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab

1 reference

12 December 2020

TNF-R1 signaling: a beautiful pathway

1 reference

12 December 2020

Infliximab treatment of rheumatoid arthritis and Crohn's disease

1 reference

12 December 2020

Successful treatment of severe psoriasis and psoriatic arthritis with adalimumab.

1 reference

12 December 2020

Long-term efficacy and safety of infliximab in the treatment of ankylosing spondylitis: an open, observational, extension study of a three-month, randomized, placebo-controlled trial

1 reference

12 December 2020

Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation.

1 reference

12 December 2020

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

1 reference

12 December 2020

Systematic safety follow up in a cohort of 107 patients with spondyloarthropathy treated with infliximab: a new perspective on the role of host defence in the pathogenesis of the disease?

1 reference

12 December 2020

Human antibodies by design

1 reference

12 December 2020

Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-alpha monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris

1 reference

12 December 2020

Immunogenicity of therapeutic monoclonal antibodies

1 reference

12 December 2020

A novel monoclonal antibody design for radioimmunotherapy

1 reference

12 December 2020

The clinical significance of HAMA in patients treated with mouse monoclonal antibodies

1 reference

12 December 2020